174 related articles for article (PubMed ID: 31327188)
1. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
[No Abstract] [Full Text] [Related]
2. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Lye DC; Hughes A; O'Brien D; Athan E
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
[TBL] [Abstract][Full Text] [Related]
3. Anidulafungin for Candida glabrata infective endocarditis.
De Rosa FG; D'Avolio A; Corcione S; Baietto L; Raviolo S; Centofanti P; Pasero D; Rinaldi M; Di Perri G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4552-3. PubMed ID: 22644027
[No Abstract] [Full Text] [Related]
4. [Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Roel JE; Gamba A; Curone M; Pescio A; Bruno C; Finquelievich J
Medicina (B Aires); 1998; 58(3):301-2. PubMed ID: 9713102
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata.
Corcione S; D'Avolio A; Pasero D; Trentalange A; Pagani N; Sanguinetti M; De Rosa FG
Infez Med; 2019 Sep; 27(3):328-331. PubMed ID: 31545778
[TBL] [Abstract][Full Text] [Related]
6. Abdominal candidiasis is a hidden reservoir of echinocandin resistance.
Shields RK; Nguyen MH; Press EG; Clancy CJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7601-5. PubMed ID: 25288081
[TBL] [Abstract][Full Text] [Related]
7. [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Piñar D; Reus S; Pérez P; Quiles JA
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):66-7. PubMed ID: 19419799
[No Abstract] [Full Text] [Related]
8. FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.
Costa-de-Oliveira S; Marcos Miranda I; Silva RM; Pinto E Silva A; Rocha R; Amorim A; Gonçalves Rodrigues A; Pina-Vaz C
Antimicrob Agents Chemother; 2011 Mar; 55(3):1312-4. PubMed ID: 21149621
[TBL] [Abstract][Full Text] [Related]
9. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
10. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Lejko-Zupanc T; Kozelj M
J Infect; 1997 Jul; 35(1):81-2. PubMed ID: 9279731
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.
Bordallo-Cardona MÁ; Escribano P; de la Pedrosa EG; Marcos-Zambrano LJ; Cantón R; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872063
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for
Wright WF; Bejou N; Shields RK; Marr K; McCarty TP; Pappas PG
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31345844
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine.
Dumaine V; Eyrolle L; Baixench MT; Paugam A; Larousserie F; Padoin C; Tod M; Salmon D
Int J Antimicrob Agents; 2008 Apr; 31(4):398-9. PubMed ID: 18242959
[No Abstract] [Full Text] [Related]
14. Caspofungin as treatment for Candida glabrata hip infection.
Lejko-Zupanc T; Mozina E; Vrevc F
Int J Antimicrob Agents; 2005 Mar; 25(3):273-4. PubMed ID: 15737527
[No Abstract] [Full Text] [Related]
15. Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.
Czerwiec FS; Bilsker MS; Kamerman ML; Bisno AL
Am J Med; 1993 May; 94(5):545-546. PubMed ID: 8498400
[No Abstract] [Full Text] [Related]
16. Endocarditis caused by Candida dubliniensis.
Garcia J; Soch K; Matthew E; Surani S; Horseman MA
Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
[TBL] [Abstract][Full Text] [Related]
17.
Bordallo-Cardona MÁ; Agnelli C; Gómez-Nuñez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397068
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
19. [Endocarditis due to Candida glabrata on a prosthetic valve].
Sastre Rincón JA; Dalmau Sorli MJ; López Correa T
Rev Esp Anestesiol Reanim; 2012; 59(6):345. PubMed ID: 22542877
[No Abstract] [Full Text] [Related]
20. The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
Nishida T; Mayumi H; Kawachi Y; Tokunaga S; Maruyama Y; Nakashima A; Yasui H; Tokunaga K
Surg Today; 1994; 24(7):651-4. PubMed ID: 7949778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
